Qualigen Therapeutics (QLGN) Competitors $1.90 +0.14 (+7.95%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$1.90 +0.01 (+0.26%) As of 08/15/2025 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QLGN vs. FLGC, GOVX, PHXM, LGVN, HOOK, SNPX, TAOX, XFOR, PHIO, and IBIOShould you be buying Qualigen Therapeutics stock or one of its competitors? The main competitors of Qualigen Therapeutics include Flora Growth (FLGC), GeoVax Labs (GOVX), PHAXIAM Therapeutics (PHXM), Longeveron (LGVN), HOOKIPA Pharma (HOOK), Synaptogenix (SNPX), Synaptogenix (TAOX), X4 Pharmaceuticals (XFOR), Phio Pharmaceuticals (PHIO), and iBio (IBIO). These companies are all part of the "pharmaceutical products" industry. Qualigen Therapeutics vs. Its Competitors Flora Growth GeoVax Labs PHAXIAM Therapeutics Longeveron HOOKIPA Pharma Synaptogenix Synaptogenix X4 Pharmaceuticals Phio Pharmaceuticals iBio Flora Growth (NASDAQ:FLGC) and Qualigen Therapeutics (NASDAQ:QLGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Does the media favor FLGC or QLGN? In the previous week, Flora Growth had 1 more articles in the media than Qualigen Therapeutics. MarketBeat recorded 4 mentions for Flora Growth and 3 mentions for Qualigen Therapeutics. Flora Growth's average media sentiment score of 1.15 beat Qualigen Therapeutics' score of 0.75 indicating that Flora Growth is being referred to more favorably in the media. Company Overall Sentiment Flora Growth Positive Qualigen Therapeutics Positive Which has more volatility and risk, FLGC or QLGN? Flora Growth has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Comparatively, Qualigen Therapeutics has a beta of -0.17, indicating that its share price is 117% less volatile than the S&P 500. Is FLGC or QLGN more profitable? Qualigen Therapeutics has a net margin of 0.00% compared to Flora Growth's net margin of -24.86%. Qualigen Therapeutics' return on equity of 0.00% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Flora Growth-24.86% -261.57% -48.06% Qualigen Therapeutics N/A N/A -212.63% Do institutionals & insiders hold more shares of FLGC or QLGN? 36.0% of Flora Growth shares are held by institutional investors. Comparatively, 3.2% of Qualigen Therapeutics shares are held by institutional investors. 12.6% of Flora Growth shares are held by company insiders. Comparatively, 1.8% of Qualigen Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer FLGC or QLGN? Flora Growth presently has a consensus price target of $93.00, suggesting a potential upside of 293.53%. Given Flora Growth's stronger consensus rating and higher possible upside, research analysts clearly believe Flora Growth is more favorable than Qualigen Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Qualigen Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings and valuation, FLGC or QLGN? Qualigen Therapeutics has lower revenue, but higher earnings than Flora Growth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlora Growth$59.51M0.23-$15.91M-$34.38-0.69Qualigen Therapeutics$4.98M0.63-$6.26MN/AN/A SummaryFlora Growth beats Qualigen Therapeutics on 10 of the 14 factors compared between the two stocks. Get Qualigen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for QLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QLGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QLGN vs. The Competition Export to ExcelMetricQualigen TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.88M$2.75B$5.67B$9.82BDividend YieldN/A1.77%3.79%4.07%P/E RatioN/A21.8930.5825.12Price / Sales0.63740.48464.45115.80Price / CashN/A177.1637.4059.05Price / Book-0.465.079.096.18Net Income-$6.26M$31.61M$3.25B$264.89M7 Day Performance4.40%25.12%7.32%4.18%1 Month Performance-51.65%3.84%5.42%1.99%1 Year Performance-80.43%10.43%30.66%24.22% Qualigen Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QLGNQualigen TherapeuticsN/A$1.90+8.0%N/A-80.7%$2.88M$4.98M0.0050Earnings ReportShort Interest ↑FLGCFlora Growth3.3242 of 5 stars$19.71-4.3%$93.00+371.8%-34.1%$11.28M$59.51M-0.57280Positive NewsShort Interest ↓GOVXGeoVax Labs1.8494 of 5 stars$0.68+0.3%$8.88+1,201.7%-77.3%$10.86M$3.95M-0.3410Short Interest ↑PHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58MN/A0.0049LGVNLongeveron3.692 of 5 stars$0.69-1.5%$8.67+1,165.2%-69.1%$10.40M$2.39M-0.1120News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpHOOKHOOKIPA Pharma3.4598 of 5 stars$0.85+3.8%$4.50+428.2%-83.0%$10.39M$9.35M-0.15160Short Interest ↓SNPXSynaptogenixN/A$7.39+20.0%N/A+154.7%$10.27MN/A-0.734Gap DownHigh Trading VolumeTAOXSynaptogenixN/A$7.37-0.3%N/AN/A$10.24MN/A-0.734Positive NewsEarnings ReportAnalyst DowngradeXFORX4 Pharmaceuticals4.3641 of 5 stars$1.80+26.7%$72.33+3,920.8%-85.0%$10.16M$2.56M-0.1280News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionGap DownHigh Trading VolumePHIOPhio Pharmaceuticals2.5748 of 5 stars$2.06-3.5%$14.00+581.3%-15.5%$9.92MN/A-0.3210News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Gap DownIBIOiBio1.1947 of 5 stars$0.58-1.4%$5.00+765.1%-59.9%$9.55M$375K0.00100 Related Companies and Tools Related Companies FLGC Competitors GOVX Competitors PHXM Competitors LGVN Competitors HOOK Competitors SNPX Competitors TAOX Competitors XFOR Competitors PHIO Competitors IBIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QLGN) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access